CannaVision Receives $225k From Private Investor Equity Placement
/EINPresswire.com/ -- LAS VEGAS, NV--(Marketwired - Sep 18, 2017) - StereoVision Entertainment, Inc. (
"These funds raised through a $.50 per share with registration rights equity placement will be used to file an SEC S-1 registration statement to bring CannaVision to fully reporting status with the SEC and fulfill our special dividend free trading share commitment to the StereoVision shareholders, bringing the number of CannaVision shareholders to over 500 which helps us qualify to move our listing up to a higher exchange, and, to open our next Compassionate Care Medical Cannabis Holistic Pain Management Clinic in Port Charlotte, Florida," said CannaVision President Marla Mahloch. "We're following up with a $1.5mil mezzanine equity round. Contact the Company for details. Please be advised, as the recovery from hurricane Irma continues our Coral Gables Compassionate Care Medical Cannabis Holistic Pain Management Clinic at 1801 SW 22nd St. (Coral Way) #405 Coral Gables, Florida is open and receiving patients. Call 305-302-5599 for appointments. Walk-ins welcome!"
StereoVision Entertainment http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release, whether as a result of future events or otherwise.
Contact:
Jessica Valencia
305-302-5599
info@cannavisionclinics.com
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.